{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:48:12Z","timestamp":1782236892708,"version":"3.54.5"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>Osteopontin (OPN) is a multifunctional glycoprotein that physiologically interacts with different types of integrins. It is considered to be a possible prognostic biomarker in certain tumor types; however, various splicing isoforms exist, which have not been investigated in melanoma. We aimed to define the relative expression pattern of five <jats:italic>OPN<\/jats:italic> isoforms and clarify the prognostic significance of the splice variants in melanoma. We also aimed to investigate the expression pattern of eight integrins in the same tumors. Gene expression analyses revealed that the relative expression of <jats:italic>OPNa, OPNb<\/jats:italic>, and <jats:italic>OPNc<\/jats:italic> is significantly higher in metastatic tumors compared to primary lesions (<jats:italic>p<\/jats:italic> &amp;lt; 0.01), whereas the expression of <jats:italic>OPN4<\/jats:italic> and <jats:italic>OPN5<\/jats:italic> was low in both. The more aggressive nodular melanomas had higher expression levels compared to the superficial spreading subtype (<jats:italic>p<\/jats:italic> \u2264 0.05). The relative expression of the eight tested integrins was low, with only the expression of <jats:italic>ITGB3<\/jats:italic> being detectable in nodular melanoma (Median<jats:sub>log2<\/jats:sub> = 1.274). A positive correlation was found between Breslow thickness and the expression of <jats:italic>OPNc<\/jats:italic> variant, whereby thicker tumors (&amp;gt;4\u00a0mm) had significantly higher expression (<jats:italic>p<\/jats:italic> \u2264 0.05). The Breslow thickness was negatively correlated with the expression of <jats:italic>OPN4<\/jats:italic>, and similarly with <jats:italic>ITGA2<\/jats:italic>. <jats:italic>OPNc<\/jats:italic> also exhibited significant positive correlation with the presence of metastasis. Our data show that high expression of <jats:italic>OPNa<\/jats:italic>, <jats:italic>OPNb<\/jats:italic>, and especially <jats:italic>OPNc<\/jats:italic> and low expression of <jats:italic>OPN4<\/jats:italic> and <jats:italic>ITGA2<\/jats:italic> are associated with an advanced stage of tumor progression and poor prognosis in melanoma.<\/jats:p>","DOI":"10.3389\/pore.2022.1610608","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T04:11:18Z","timestamp":1661314278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma"],"prefix":"10.3389","volume":"28","author":[{"given":"Krisztina","family":"J\u00e1mbor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"Koroknai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Sz\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Pik\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Bal\u00e1zs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/CMR.0000000000000753","article-title":"The Role of Osteopontin in the Development and Metastasis of Melanoma","volume":"31","author":"Zhao","year":"2021","journal-title":"Melanoma Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cncr.23147","article-title":"Osteopontin as a Molecular Prognostic Marker for Melanoma","volume":"112","author":"Rangel","year":"2008","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3892\/ijo.2018.4656","article-title":"Full-length Osteopontin and its Splice Variants as Modulators of Chemoresistance and Radioresistance (Review)","volume":"54","author":"Gimba","year":"2019","journal-title":"Int J Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"22239","DOI":"10.18632\/oncotarget.4161","article-title":"Osteopontin (OPN\/SPP1) Isoforms Collectively Enhance Tumor Cell Invasion and Dissemination in Esophageal Adenocarcinoma","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.matbio.2005.05.005","article-title":"Distinct Structural Requirements for Binding of the Integrins \u03b1v\u03b26, \u03b1v\u03b23, \u03b1v\u03b25, \u03b15\u03b21 and \u03b19\u03b21 to Osteopontin","volume":"24","author":"Yokosaki","year":"2005","journal-title":"Matrix Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12026-010-8179-5","article-title":"Intracellular Osteopontin (iOPN) and Immunity","volume":"49","author":"Inoue","year":"2011","journal-title":"Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2019.05.004","article-title":"Role of Osteopontin in Dendritic Cell Shaping of Immune Responses","volume":"50","author":"Del Prete","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1073\/pnas.1423011112","article-title":"Intracellular Osteopontin Regulates Homeostasis and Function of Natural Killer Cells","volume":"112","author":"Leavenworth","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1111\/j.1582-4934.2010.01115.x","article-title":"Role of the Metastasis-Promoting Protein Osteopontin in the Tumour Microenvironment","volume":"14","author":"Anborgh","year":"2010","journal-title":"J Cel Mol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","article-title":"Osteopontin: A Multifunctional Protein at the Crossroads of Inflammation, Atherosclerosis, and Vascular Calcification","volume":"11","author":"Cho","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.phrs.2019.04.030","article-title":"Osteopontin as a Multifaceted Driver of Bone Metastasis and Drug Resistance","volume":"144","author":"Pang","year":"2019","journal-title":"Pharmacol Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbcan.2017.02.005","article-title":"Osteopontin Splice Variants and Polymorphisms in Cancer Progression and Prognosis","volume":"1868","author":"Briones-Orta","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3892\/ijmm.2017.2964","article-title":"Human Osteopontin: Potential Clinical Applications in Cancer (Review)","volume":"39","author":"Hao","year":"2017","journal-title":"Int J Mol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E815","DOI":"10.3390\/cells8080815","article-title":"Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight","volume":"8","author":"Lamort","year":"2019","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.canep.2013.08.005","article-title":"Prognostic Values of Osteopontin-C, E-Cadherin and Beta-Catenin in Breast Cancer","volume":"37","author":"Pang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55572","DOI":"10.18632\/oncotarget.10865","article-title":"Integrin \u03b23 and CD44 Levels Determine the Effects of the OPN-A Splicing Variant on Lung Cancer Cell Growth","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3892\/ol.2019.9905","article-title":"Osteopontin as a Biomarker for Osteosarcoma Therapy and Prognosis","volume":"17","author":"Han","year":"2019","journal-title":"Oncol Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/biomedicines9101372","article-title":"Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms","volume":"9","author":"Viana","year":"2021","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3390\/cancers13153793","article-title":"Osteopontin as a Regulator of Colorectal Cancer Progression and its Clinical Applications","volume":"13","author":"Amilca-Seba","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e54958","DOI":"10.1371\/journal.pone.0054958","article-title":"Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration","volume":"8","author":"Rakosy","year":"2013","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1007\/s13277-015-3495-y","article-title":"The Role of Osteopontin Expression in Melanoma Progression","volume":"36","author":"Kiss","year":"2015","journal-title":"Tumour Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/07357907.2021.1933015","article-title":"Assessing SPP1\/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential","volume":"39","author":"Chou","year":"2021","journal-title":"Cancer Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41379-019-0402-x","article-title":"Melanoma Pathology Reporting and Staging","volume":"33","author":"Scolyer","year":"2020","journal-title":"Mod Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.3390\/cancers13236058","article-title":"Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines","volume":"13","author":"Patel","year":"2021","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","first-page":"581395","DOI":"10.3389\/pore.2021.581395","article-title":"Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells","volume":"27","author":"Kiss","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/CMR.0000000000000588","article-title":"Molecular Alterations Associated with Acquired Resistance to BRAFV600E Targeted Therapy in Melanoma Cells","volume":"29","author":"Szasz","year":"2019","journal-title":"Melanoma Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16340","DOI":"10.18632\/oncotarget.14092","article-title":"The Embryonic Type of SPP1 Transcriptional Regulation is Re-activated in Glioblastoma","volume":"8","author":"Kijewska","year":"2017","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"pkaa097","DOI":"10.1093\/jncics\/pkaa097","article-title":"Subtyping Cutaneous Melanoma Matters","volume":"4","author":"El Sharouni","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/cells10071820","article-title":"Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer","volume":"10","author":"Hao","year":"2021","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2251-6581-13-13","article-title":"Tertiary Structure Prediction and Identification of Druggable Pocket in the Cancer Biomarker - Osteopontin-C","volume":"13","author":"Sivakumar","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/sj.onc.1209248","article-title":"An Osteopontin Splice Variant Induces Anchorage Independence in Human Breast Cancer Cells","volume":"25","author":"He","year":"2006","journal-title":"Oncogene"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.1074\/jbc.M110.189258","article-title":"Osteopontin Undergoes Polymerization In Vivo and Gains Chemotactic Activity for Neutrophils Mediated by Integrin Alpha9beta1","volume":"286","author":"Nishimichi","year":"2011","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1158\/1541-7786.MCR-10-0463","article-title":"Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression","volume":"9","author":"Tilli","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8339","DOI":"10.1007\/s11033-020-05867-9","article-title":"Osteopontin-4 and Osteopontin-5 Splice Variants are Expressed in Several Tumor Cell Lines","volume":"47","author":"Silva","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2559.1994.tb00517.x","article-title":"Emergence of \u03b15\u03b21 Fibronectin- and \u03b1v\u03b23 Vitronectin-Receptor Expression in Melanocytic Tumour Progression","volume":"24","author":"Danen","year":"1994","journal-title":"Histopathology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/(sici)1097-0142(19990115)85:2<375:aid-cncr15>3.0.co;2-1","article-title":"Molecular Prognostic Markers in Intermediate-Thickness Cutaneous Malignant Melanoma","volume":"85","author":"Hieken","year":"1999","journal-title":"Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/ijd.14850","article-title":"The Role of Integrins in Melanoma: A Review","volume":"59","author":"Arias-Mejias","year":"2020","journal-title":"Int J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-018-0763-x","article-title":"Integrins as Therapeutic Targets in the Organ-specific Metastasis of Human Malignant Melanoma","volume":"37","author":"Huang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/Cmr.0000000000000322","article-title":"Altered Integrin Expression Patterns Shown by Microarray in Human Cutaneous Melanoma","volume":"27","author":"Vizkeleti","year":"2017","journal-title":"Melanoma Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3892\/or.2013.2813","article-title":"Evaluation of the Expression of Stem Cell Markers in Human Breast Cancer Reveals a Correlation with Clinical Progression and Metastatic Disease in Ductal Carcinoma","volume":"31","author":"Martin","year":"2014","journal-title":"Oncol Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1172\/JCI42328","article-title":"The \u03b1\u03b2 Integrin is a Metastasis Suppressor in Mouse Models and Human Cancer","volume":"121","author":"Ramirez","year":"2011","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-94-017-9153-3_3","article-title":"\u03b12\u03b21 Integrin","volume":"819","author":"Madamanchi","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.18632\/oncotarget.13832","article-title":"VE-Cadherin RGD Motifs Promote Metastasis and Constitute a Potential Therapeutic Target in Melanoma and Breast Cancers","volume":"8","author":"Bartolome","year":"2017","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1158\/0008-5472.CAN-09-0315","article-title":"Integrin Alpha2 Mediates Selective Metastasis to the Liver","volume":"69","author":"Yoshimura","year":"2009","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.semcancer.2015.08.004","article-title":"Alpha2beta1 Integrin in Cancer Development and Chemoresistance","volume":"35","author":"Naci","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/j.1538-7836.2005.01273.x","article-title":"Platelet Glycoprotein I(b)alpha and Integrin Alpha2 Beta1 Polymorphisms: Gene Frequencies and Linkage Disequilibrium in a Population Diversity Panel","volume":"3","author":"Di Paola","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e8743","DOI":"10.1371\/journal.pone.0008743","article-title":"Enhanced Binding of poly(ADP-Ribose)polymerase-1 and Ku80\/70 to the ITGA2 Promoter via an Extended Cytosine-Adenosine Repeat","volume":"5","author":"Cheli","year":"2010","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gendis.2018.12.003","article-title":"Regulation and Functions of Integrin \u03b12 in Cell Adhesion and Disease","volume":"6","author":"Adorno-Cruz","year":"2019","journal-title":"Genes Dis"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T04:11:28Z","timestamp":1661314288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":49,"alternative-id":["10.3389\/pore.2022.1610608"],"URL":"https:\/\/doi.org\/10.3389\/pore.2022.1610608","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"article-number":"1610608"}}